Dyne Therapeutics, Inc.

DYN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001818794

SEC filings (opens in a new tab)

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Dyne Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of DYN: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	193	1	200	+8
Shares	111.0M	7.39M	112.4M	+8.82M (+8.5%)
Value	$3.92B	$260.7M	$4.03B	+$377.3M (+10.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DYN in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	7,794,114	$280.0M	0.01%
Siren, L.L.C.	1,134,664	$40.8M	2.04%
Man Group plc	718,650	$25.8M	0.07%
Perceptive Advisors LLC	718,144	$25.8M	0.55%
Deerfield Management Company, L.P. (Series C)	435,653	$15.6M	0.23%
Balyasny Asset Management LLC	245,110	$8.80M	0.02%
Avidity Partners Management LP	165,000	$5.93M	0.30%
Neuberger Berman Group LLC	137,066	$4.92M	0.00%
Ghost Tree Capital, LLC	100,000	$3.59M	1.23%
HighVista Strategies LLC	65,482	$2.35M	0.81%
Sphera Funds Management Ltd.	56,504	$2.03M	0.33%
State of New Jersey Common Pension Fund D	44,197	$1.59M	0.01%
Connor, Clark & Lunn Investment Management Ltd.	41,157	$1.48M	0.01%
Guggenheim Capital LLC	31,857	$1.14M	0.01%
Y-Intercept (Hong Kong) Ltd	29,694	$1.07M	0.07%
Intech Investment Management LLC	25,814	$927.2K	0.01%
Qube Research & Technologies Ltd	23,166	$832.1K	0.00%
XTX Topco Ltd	15,943	$572.7K	0.04%
Dynamic Technology Lab Private Ltd	11,970	$430.0K	0.05%
Advantage Alpha Capital Partners LP	10,737	$385.7K	0.09%
Engineers Gate Manager LP	9,776	$351.2K	0.01%
Dark Forest Capital Management LP	9,307	$334.3K	0.04%
HSBC Holdings PLC	9,176	$326.0K	0.00%
Hanseatic Management Services Inc	7,183	$258.0K	0.37%
Millennium Management LLC	5,991	$215.2K	0.00%
Acadian Asset Management LLC	4,538	$163.0K	0.00%
Values First Advisors, Inc.	1,720	$61.8K	0.03%
Point72 (DIFC) Ltd	992	$35.6K	0.00%
Quantbot Technologies LP	959	$34.4K	0.00%
ADAR1 Capital Management, LLC	400	$14.4K	0.00%
Steward Partners Investment Advisory, LLC	375	$13.5K	0.00%
Truvestments Capital LLC	295	$10.6K	0.00%
Asset Dedication, LLC	103	$3.70K	0.00%
True Wealth Design, LLC	98	$3.52K	0.00%
Sterling Capital Management LLC	83	$2.98K	0.00%
Capital Performance Advisors LLP	81	$2.91K	0.00%
Bessemer Group Inc	60	$2.00K	0.00%
Federation des caisses Desjardins du Quebec	20	$718	0.00%
CVA Family Office, LLC	12	$431	0.00%
J.Safra Asset Management Corp	11	$372	0.00%
Farther Finance Advisors, LLC	3	$108	0.00%
National Bank of Canada	1	$36	0.00%

Sold out (34)

Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DYN in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Artal Group S.A.	1,516,960	$53.5M
LMR Partners LLP	477,000	$16.8M
Lord, Abbett & Co. LLC	452,213	$16.0M
Marshall Wace, LLP	273,567	$9.65M
Vestal Point Capital, LP	225,000	$7.94M
Atika Capital Management LLC	181,500	$6.41M
Two Sigma Investments, LP	159,154	$5.62M
EAM Global Investors LLC	127,247	$4.49M
Renaissance Technologies LLC	126,000	$4.45M
EAM Investors, LLC	107,250	$3.78M
Affinity Asset Advisors, LLC	100,000	$3.53M
Integral Health Asset Management, LLC	100,000	$3.53M
BCJ Capital Management, LLC	99,959	$3.53M
Walleye Capital LLC	85,652	$3.02M
Monashee Investment Management LLC	85,000	$3.00M
Cinctive Capital Management LP	34,529	$1.22M
Alyeska Investment Group, L.P.	25,000	$882.3K
Omers Administration Corp	23,600	$832.8K
SEI Investments Co	18,092	$638.5K
Standard Life Aberdeen plc	17,869	$630.6K
Gilder Gagnon Howe & Co LLC	17,546	$619.2K
Legato Capital Management LLC	15,480	$546.3K
Alpine Global Management, LLC	12,460	$439.7K
Brevan Howard Capital Management LP	10,053	$354.8K
Simplex Trading, LLC	7,583	$267.0K
Graham Capital Management, L.P.	6,618	$233.5K
American Century Companies Inc	6,451	$227.7K
Mirabella Financial Services LLP	5,698	$201.1K
EntryPoint Capital, LLC	2,479	$87.5K
Pacer Advisors, Inc.	827	$29.2K
Wetzel Investment Advisors, Inc.	1,000	$28.4K
Group One Trading, L.P.	725	$25.6K
Innealta Capital, LLC	81	$2.86K
Headlands Technologies LLC	1	$35

Not filed for Q3 2024 yet (1)

Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYN in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	7,386,988	$260.7M